Motus GI Holdings, Inc. (MOTS)

USD 0.0

(0.0%)

EBITDA Summary of Motus GI Holdings, Inc.

  • Motus GI Holdings, Inc.'s latest annual EBITDA in 2023 was -11.23 Million USD , up 35.1% from previous year.
  • Motus GI Holdings, Inc.'s latest quarterly EBITDA in 2024 Q1 was -2.02 Million USD , up 18.56% from previous quarter.
  • Motus GI Holdings, Inc. reported an annual EBITDA of -16.5 Million USD in 2022, up 4.2% from previous year.
  • Motus GI Holdings, Inc. reported an annual EBITDA of -17.48 Million USD in 2021, up 3.88% from previous year.
  • Motus GI Holdings, Inc. reported a quarterly EBITDA of -3.94 Million USD for 2023 Q1, down -14.43% from previous quarter.
  • Motus GI Holdings, Inc. reported a quarterly EBITDA of -2.28 Million USD for 2023 Q3, up 11.76% from previous quarter.

Annual EBITDA Chart of Motus GI Holdings, Inc. (2023 - 2015)

Historical Annual EBITDA of Motus GI Holdings, Inc. (2023 - 2015)

Year EBITDA EBITDA Growth
2023 -11.23 Million USD 35.1%
2022 -16.5 Million USD 4.2%
2021 -17.48 Million USD 3.88%
2020 -18.16 Million USD 19.8%
2019 -23.21 Million USD -50.66%
2018 -18.73 Million USD -18.26%
2017 -13.15 Million USD -67.15%
2016 -7.86 Million USD -33.06%
2015 -5.91 Million USD 0.0%

Peer EBITDA Comparison of Motus GI Holdings, Inc.

Name EBITDA EBITDA Difference
Babylon Holdings Limited -176.72 Million USD 93.646%
ETAO International Co., Ltd. -893.88 Million USD 98.744%
MedAvail Holdings, Inc. -41.76 Million USD 73.111%
Micron Solutions, Inc. -308.4 Thousand USD -3541.363%
ThermoGenesis Holdings, Inc. -7.74 Million USD -45.09%
Titan Medical Inc. 7.51 Million USD 249.347%
UpHealth, Inc. -16.89 Million USD 33.535%